The most likely alternative interpretation is that depletion of CD4+CD8α+ T cells after either anti-CD4 or anti-CD8α treatment could have abrogated protection against TB, implicating these DP cells as a cellular source of i.v. BCG–mediated immunity. This evidence concerns the gene CD8A and tuberculosis.